Name | CCAAT/enhancer-binding protein beta | ||
UniProt ID | CEBPB_HUMAN | ||
Gene Name | CEBPB | ||
Gene ID | 1051 | ||
Synonyms |
CEBPB, C/EBP-beta, IL6DBP, NF-IL6, TCF5
|
||
Sequence |
MQRLVAWDPACLPLPPPPPAFKSMEVANFYYEADCLAAAYGGKAAPAAPPAARPGPRPPA
GELGSIGDHERAIDFSPYLEPLGAPQAPAPATATDTFEAAPPAPAPAPASSGQHHDFLSD LFSDDYGGKNCKKPAEYGYVSLGRLGAAKGALHPGCFAPLHPPPPPPPPPAELKAEPGFE PADCKRKEEAGAPGGGAGMAAGFPYALRAYLGYQAVPSGSSGSLSTSSSSSPPGTPSPAD AKAPPTACYAGAAPAPSQVKSKAKKTVDKHSDEYKIRRERNNIAVRKSRDKAKMRNLETQ HKVLELTAENERLQKKVEQLSRELSTLRNLFKQLPEPLLASSGHC |
||
Pathway Map | MAP LINK | ||
KEGG ID | hsa1051 | ||
TTD ID | T10252 | ||
Pfam | PF00170; PF03131; PF04977; PF06785; PF07716; PF08614; PF09728; PF11932; PF13874; PF15456; PF15799 |
Pair Name | All-trans retinoic acid, Midostaurin | |||
Phytochemical | All-trans-retinoic acid | |||
Drug | Midostaurin | |||
Disease Info | [ICD-11: 2A60.Z] | Acute myeloid leukemia | Investigative | |
Regulate Info | Up-regulation | CCAAT/enhancer-binding protein beta | Expression | |
Result | Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3 |